Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Edwards Lifesciences
(NY:
EW
)
89.14
-0.97 (-1.08%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Edwards Lifesciences
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
October 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...
Via
Benzinga
Edwards Lifesciences Corporation (EW) Q3 2021 Earnings Call Transcript
October 27, 2021
EW earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Edwards Lifesciences Q3 Earnings
October 27, 2021
Edwards Lifesciences (NYSE:EW) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:15 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Edwards Topples As Full-Year Guidance Comes In Light After Mixed Quarter
October 27, 2021
The company retained guidance for adjusted profit of $2.07-$2.27, missing the midpoint of analysts' view.
Via
Investor's Business Daily
Earnings Scheduled For October 27, 2021
October 27, 2021
Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion. • General...
Via
Benzinga
Where Edwards Lifesciences Stands With Analysts
August 21, 2021
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:
Via
Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Exposures
Product Safety
Notable Edwards Lifesciences Insider Trades $4.6M In Company Stock
October 04, 2021
Michael Mussallem, Chairman And CEO at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Insider Development Of Edwards Lifesciences Trades $1.59 Million In Company Stock
September 13, 2021
Donald Bobo Jr, insider at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on September 10, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Unusual Options Activity Insight: Edwards Lifesciences
August 10, 2021
Edwards Lifesciences (NYSE:EW) shares experienced unusual opt...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Expert Ratings for Edwards Lifesciences
August 02, 2021
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW...
Via
Benzinga
Notable Edwards Lifesciences Insider Trades $1.39 Million In Company Stock
September 09, 2021
Catherine Szyman, Insider at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on September 8, according to a new SEC filing. What Happened: A Form...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
What 16 Analyst Ratings Have To Say About Edwards Lifesciences
July 30, 2021
Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings with...
Via
Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
'Fast Money Halftime Report' Picks For August 17
August 17, 2021
On CNBC's "Fast Money Halftime Report," Josh Brown said Chipotle Mexican Grill, Inc. (NYSE: CMG) looks really strong on a weak tape. He likes the stock. Joe...
Via
Benzinga
10 Biggest Price Target Changes For Monday
August 02, 2021
Raymond James raised Edwards Lifesciences Corporation (NYSE:
Via
Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...
Via
Benzinga
Edwards Lifesciences Beats Q2 Earnings On Demand Recovery, Boosts FY2021 Guidance; Analysts Raise Price Target
July 30, 2021
Edwards Lifesciences a cardio device company, reported Q2 earnings of $489.5 million, or $0.64, ahead of the consensus of $0.55.
Via
Talk Markets
Edwards Lifesciences Beats Q2 Earnings On Demand Recovery, Boosts FY2021 Guidance; Analysts Raise Price Target
July 30, 2021
Edwards Lifesciences (NYSE: EW), a cardio device company, reported Q2 earnings of $489.5 million, or $0.64, ahead of the consensus of $0.55. "Vaccine adoption in...
Via
Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
August 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Highs On Monday
August 23, 2021
Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG...
Via
Benzinga
Stocks That Hit 52-Week Highs On Friday
August 20, 2021
Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high...
Via
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Stock Market Rally Pauses Near Highs Amid Earnings From Apple, Microsoft, Tesla, Amazon, Google, Facebook
July 30, 2021
The market rally paused on the key indexes amid earnings from Apple, Tesla and Amazon. But several stocks flashed buy signals.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.